C33H39ClN4O6
Neat
623.10
-20ºC
Room Temperature
CPT 11, Campto, CPT-11, Camptothecin 11 hydrochloride, DTXSID6045953, U 101440E, Irinotecan hydrochloride anhydrous, 06X131E4OE, 7-Ethyl-10-(4-(1-piperidino)-1-piperidino)carbonyloxy camptothecin hydrochloride, CHEBI:5971, DTXCID4025953, irinotecan hydrochloride (anhydrous), NSC-759878, DQ-2805, U-101440E, CPT11, Irinomedac, Irinotecan hydrochloide, RefChem:56367, Irinotecan Hydrochloride 40 mg/2 mL, Irinotecan Hydrochloride 100 mg/5 mL, (1, 4'-Bipiperidine)-1'-carboxylic acid, 4, 11-diethyl-3, 4, 12, 14-tetrahydro-4-hydroxy-3, 14-dioxo-1H-pyrano(3', 4':6, 7)indolizino(1, 2-b)quinolin-9-yl ester, monohydrochloride, trihydrate, (S)-, 042LAQ1IIS, Irinotecan Monohydrochloride Trihydrate, Onivyde, U-101, 440E, Irinotecan Hcl, Topotecin, (S)-4, 11-diethyl-4-hydroxy-3, 14-dioxo-3, 4, 12, 14-tetrahydro-1H-pyrano[3', 4':6, 7]indolizino[1, 2-b]quinolin-9-yl [1, 4'-bipiperidine]-1'-carboxylate hydrochloride, Irinotecan (hydrochloride), MFCD01862255, NSC-616348, [(19S)-10, 19-diethyl-19-hydroxy-14, 18-dioxo-17-oxa-3, 13-diazapentacyclo[11.8.0.02, 11.04, 9.015, 20]henicosa-1(21), 2, 4(9), 5, 7, 10, 15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride, [1, 4'-Bipiperidine]-1'-carboxylic acid, (4S)-4, 11-diethyl-3, 4, 12, 14-tetrahydro-4-hydroxy-3, 14-dioxo-1H-pyrano[3', 4':6, 7]indolizino[1, 2-b]quinolin-9-yl ester, monohydrochloride, NCGC00095190-01, (19S)-10, 19-Diethyl-19-hydroxy-14, 18-dioxo-17-oxa-3, 13-diazapentacyclo[11.8.0.0[2, 11].0[4, 9].0[15, 20]]henicosa-1(21), 2(11), 3, 5, 7, 9, 15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate hydrochloride, CAS-100286-90-6, C33H39ClN4O6, UNII-06X131E4OE, Irinotecan hydrochloride [USAN:JAN], (diethyl-hydroxy-dioxo-[?]yl) 4-(1-piperidyl)piperidine-1-carboxylate, Irinotecan hydrochloirde, Irinotecan Hydrochloride?, (4S)-4, 11-DIETHYL-4-HYDROXY-3, 14-DIOXO-3, 4, 12, 14-TETRAHYDRO-1H-PYRANO[3', 4':6, 7]INDOLIZINO[1, 2-B]QUINOLIN-9-YL 1, 4'-BIPIPERIDINE-1'-CARBOXYLATE, irinotecan monohydrochloride, SCHEMBL4033, Camptosar (TN) (Pharmacia), SPECTRUM1505821, CHEMBL541887, orb1227178, orb1310566, SCHEMBL29363805, GLXC-05203, HMS1922J04, Pharmakon1600-01505821, Tox21_111479, EBC-12141, HY-16562A, NSC759878, s5026, T0486L, AKOS015901921, Tox21_111479_1, CCG-213561, FI73263, IRINOTECAN HYDROCHLORIDE [WHO-DD], NCGC00095190-02, NCGC00178697-04, (1, 4'-Bipiperidine)-1'-carboxylic acid, (4S)-4, 11-diethyl-3, 4, 12, 14-tetrahydro-4-hydroxy-3, 14-dioxo-1H-pyrano(3', 4':6, 7)indolizino(1, 2-b)quinolin-9-yl ester, monohydrochloride, (1, 4'-Bipiperidine)-1'-carboxylic acid, 3, 4, 12, 14-tetrahydro-4, 11-diethyl-4-hydroxy-3, 4-dioxo-1H-pyrano(3', 4':6, 7)indolizino(1, 2-b)quinolin-9-yl ester, monohydrochloride, (S)-, AC-28335, AS-13304, I0714, EN300-122383, IRINOTECAN HYDROCHLORIDE ANHYDROUS [MI], Irinotecan hydrochloride, topoisomerase inhibitor, SR-01000763864, SR-01000763864-3, Q27106952, Z1541760033, 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin Hydrochloride Trihydrate, (+)-7-ETHYL-10-HYDROXYCAMPTOTHECINE 10-(1, 4'-BIPIPERIDINE)-1'-CARBOXYLATE, MONOHYDROCHLORIDE, (1, 4'-BIPIPERIDINE)-1'-CARBOXYLIC ACID, (4S)-4, 11-DIETHYL-3, 4, 12, 14-TETRAHYDRO-4-HYDROXY-3, 14-DIOXO-1H-PYRANO(3', 4':6, 7)INDOLIZINO(1, 2-B)QUINOLIN-9-YL ESTER, HYDROCHLORIDE (1:1), (19S)-10, 19-diethyl-19-hydroxy-14, 18-dioxo-17-oxa-3, 13-diazapentacyclo[11.8.0.0^{2, 11}.0^{4, 9}.0^{15, 20}]henicosa-1(21), 2(11), 3, 5, 7, 9, 15(20)-heptaen-7-yl [1, 4'-bipiperidine]-1'-carboxylate hydrochloride, (4S)-4, 11-diethyl-4-hydroxy-3, 14-dioxo-3, 4, 12, 14-tetrahydro-1H-pyrano[3', 4':6, 7]indolizino[1, 2-b]quinolin-9-yl [1, 4'-bipiperidine]-1'-carboxylate hydrochloride, (4S)-4, 11-Diethyl-4-hydroxy-3, 14-dioxo-3, 4, 12, 14-tetrahydro-1H-pyrano[3', 4':6, 7]indolizino[1, 2-b]quinolin-9-yl [1, 4'-bipiperidine]-1'-carboxylate--hydrogen chloride (1/1), (4S)-4, 11-Diethyl-4-hydroxy-3, 14-dioxo-3, 4, 12, 14-tetrahydro-1H-pyrano[3', 4':6, 7]indolizino[1, 2-b]quinolin-9-yl 1, 4'-bipiperidine-1'-carboxylate hydrochloride, (S)-4, 11-diethyl-4-hydroxy-3, 14-dioxo-3, 4, 12, 14-tetrahydro-1H-pyrano[3', 4':6, 7]indolizino[1, 2-b]quinolin-9-yl[1, 4'-bipiperidine]-1'-carboxylatehydrochloride, [(19S)-10, 19-diethyl-19-hydroxy-14, 18-dioxo-17-oxa-3, 13-diazapentacyclo[11.8.0.02, 11.04, 9.015, 20]henicosa-1(21), 2, 4(9), 5, 7, 10, 15(20)-heptaen-7-yl] 4-(1-piperidyl)piperidine-1-carboxylate;hydrochloride, [(19S)-10, 19-Diethyl-19-hydroxy-14, 18-dioxo-17-oxa-3, 13-diazapentacyclo[11.8.0.02, 11.04, 9.015, 20]henicosa-1(21), 2, 4(9), 5, 7, 10, 15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate hydrochloride, [1, 4, 11-diethyl-3, 4, 12, 14-tetrahydro-4-hydroxy-3, 14-dioxo-1H-pyrano[3', 4':6, 7] indolizino[1, 2-b]quinolin-9-yl ester, monohydrochloride (S)-, [1, 4'-Bipiperidine]-1'-carboxylic acid, CPT-11, (S)-4, 11-diethyl-3, 4, 12, 14-tetrahydro-4-hydroxy-3, 14-dioxo-1H-pyrano[3', 4':6, 7]indolizino[1, 2-b]quinolin-9-yl ester, 1-[1-({[(4S)-4, 11-diethyl-4-hydroxy-3, 14-dioxo-3, 4, 12, 14-tetrahydro-1H-pyrano[3', 4':6, 7]indolizino[1 and 2-b]quinolin-9-yl]oxy}carbonyl)piperidin-4-yl]piperidin-1-ium chloride
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl
[(19S)-10, 19-diethyl-19-hydroxy-14, 18-dioxo-17-oxa-3, 13-diazapentacyclo[11.8.0.02, 11.04, 9.015, 20]henicosa-1(21), 2, 4(9), 5, 7, 10 and 15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride
InChI=1S/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1